Commission Delegated Regulation (EU) 2016/1443 of 29 June 2016 amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of certain drug precursors in the list of scheduled substances (Text with EEA relevance)
Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β
Amendment to Regulation (EC) No 273/2004
In Annex I to Regulation (EC) No 273/2004, in the table for Category 1 scheduled substances, the following rows are added: β(1R,2S)-(-)-chloroephedrine Β 2939Β 99Β 00 110925-64-9 (1S,2R)-(+)-chloroephedrine Β 2939Β 99Β 00 1384199-95-4 (1S,2S)-(+)-chloropseudoephedrine Β 2939Β 99Β 00 73393-61-0 (1R,2R)-(-)-chloropseudoephedrine Β 2939Β 99Β 00 771434-80-1β
Amendment to Regulation (EC) No 111/2005
In the Annex to Regulation (EC) No 111/2005, in the table for Category 1 scheduled substances, the following rows are added: β(1R,2S)-(-)-chloroephedrine Β 2939Β 99Β 00 110925-64-9 (1S,2R)-(+)-chloroephedrine Β 2939Β 99Β 00 1384199-95-4 (1S,2S)-(+)-chloropseudoephedrine Β 2939Β 99Β 00 73393-61-0 (1R,2R)-(-)-chloropseudoephedrine Β 2939Β 99Β 00 771434-80-1β
Entry into force
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.